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Highlights 
• Survey of sleep in children ages 2-12 with type 1 diabetes
• 67% of children met criteria for poor sleep quality
• Child sleep quality was related to glycemic control
• Sleep may be a modifiable factor to improve glycemic control
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Abstract (Word Count: 248) 
 
Objectives: Sleep has physiological and behavioral impacts on diabetes outcomes, yet little is 
known about the impact of sleep disturbances in children with type 1 diabetes. The current study 
sought to characterize sleep in children with type 1 diabetes and in their parents, and to examine 
the associations between child sleep, glycemic control and adherence, parent sleep and well-
being, parental fear of hypoglycemia, and nocturnal caregiving behavior. 
Methods: Surveys were emailed to parents of participants 2-12 years old in the T1D Exchange 
clinic registry. Clinical data were obtained from the registry for the 515 respondents. 
Results: In our sample, 67% of children met criteria for poor sleep quality. Child sleep quality 
was related to glycemic control (HbA1c of 7.9% [63 mmol/mol] in children with poor sleep 
quality vs 7.6% [60 mmol/mol] in children with non-poor sleep quality; P<0.001) but not mean 
frequency of blood glucose monitoring (BGM) (7.6 times/day vs 7.4 in poor/non-poor quality; 
P=0.56).  Associations were similar for sleep duration. Children with poor sleep quality were 
more likely to experience severe hypoglycemia (4% in children with poor sleep quality vs 1% in 
children with non-poor sleep quality; P=0.05) and more likely to experience DKA (7% vs 4%, 
respectively; P<0.001). Poorer child sleep quality was associated with poorer parental sleep 
quality, parental well-being, and fear of hypoglycemia (P<0.001 for all). Child sleep was not 
related to use of diabetes-related technology (CGM, insulin pump). 
Conclusions: Sleep may be a modifiable factor to improve glycemic control and reduce parental 
distress. 
Keywords: sleep quality; type 1 diabetes; glycemic control 
Abbreviations: blood glucose monitoring (BGM), continuous glucose monitoring (CGM), 
diabetic ketoacidosis (DKA), Child Sleep Habits Questionnaire (CSHQ), Pittsburgh Sleep 
Quality Index (PSQI), Hypoglycemia Fear Survey (HFS-P), World Health Organization-Five-
Wellbeing Index (WHO-5), severe hypoglycemia (SH), Research Electronic Data Capture 
(REDCap) 
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1.1 Introduction 
Sleep has physiologic and behavioral impacts on many health outcomes.  Sleep 
disturbances, which include bedtime resistance or difficulty initiating sleep, night wakings, and 
insufficient sleep (1), are highly prevalent in children, occurring in 20-30% of the general 
population (2), and a recent meta-analysis found that children and adolescents with type 1 
diabetes had significantly shorter sleep duration than controls (3).  For children with type 1 
diabetes, sleep disruptions can be the result of night wakings due to hypo/hyperglycemia, as 
well as parental nocturnal diabetes caregiving behaviors (4).  Nevertheless, sleep characteristics, 
such as total sleep time, sleep/wake times, and sleep quality, are not routinely addressed in 
standards of care for youth with type 1 diabetes (5, 6). 
Accumulating evidence indicates that short sleep duration and poor quality sleep 
contribute to problems with glycemic control and adherence in adolescents and adults with type 
1 diabetes (7, 8).  The effect of sleep on glycemic control likely occurs through a direct 
physiological pathway (decreased insulin sensitivity) (9-12) and an indirect behavioral pathway 
(insufficient sleep compromises the cognitive functions needed to effectively manage diabetes) 
(13).  One of the only studies to examine sleep in youth with type 1 diabetes used actigraphy and 
polysomnography and found that adolescents with type 1 diabetes (n=40, ages 10-16) spent less 
time in slow wave sleep than matched controls.  Adolescents with reduced slow wave sleep had 
worse glycemic control and poorer self-reported quality of life (8).  In this study, poor sleep 
habits also were associated with behavior problems and academic difficulties, but sleep was not 
examined in relation to adherence.  In a more recent study of adolescents and young adults with 
type 1 diabetes (ages 13-20), shorter self-reported sleep duration was significantly associated 
with a lower frequency of blood glucose checks, and sleep quality was significantly related to 
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glycemic control for males but not females (14).  In a smaller study of adolescents (n=45), sleep 
duration was significantly associated with adherence, measured with frequency of blood glucose 
monitoring (BGM) and insulin bolus (15). While these studies generally support the link between 
sleep disturbances and glycemic control, they have not examined the role of sleep on adherence 
to diabetes management in younger children, or the influence of diabetes-related technology, 
such as continuous glucose monitoring (CGM) or insulin pumps on sleep quality.  
Characterizing sleep patterns and disturbances and their impacts in youth with type 1 
diabetes will inform future studies designed to improve diabetes management and diabetes 
outcomes.  Previous studies of sleep in type 1 diabetes have been limited by small sample 
sizes and narrow age ranges, and children with type 1 diabetes are likely to experience unique 
sleep disturbances related to nocturnal caregiving. We used validated survey measures to 
evaluate sleep patterns in youth enrolled in the T1D Exchange clinic registry and their parents.  
In addition, we examined the associations between sleep and diabetes outcomes (hemoglobin 
A1c [HbA1c], hypoglycemia, diabetic ketoacidosis [DKA]), use of diabetes-related technology 
(insulin pump, CGM), and BGM.  Finally, we explored relationships between parental well-
being, fear of hypoglycemia, nocturnal caregiving and children’s sleep patterns. 
2.1 Materials and Methods 
2.2 Survey Components 
 We used parental surveys to characterize sleep patterns in youth 2-12 years of age with 
type 1 diabetes and their parents.  We administered both the validated Child Sleep Habits 
Questionnaire (CSHQ) (16) and Pittsburgh Sleep Quality Index (PSQI) (17).  The CSHQ is a 
parent-reported measure of child sleep habits and sleep disturbances, validated for use in ages 2-
12 (18, 19).  CSHQ scores range from 33 to 99, with higher scores indicating greater sleep 
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disturbance.  A score of 41 or higher is considered clinically significant.  The PSQI is a self-
reported measure of sleep quality and was used to assess parental sleep quality.  PSQI scores 
range from 0 to 21 with a higher score indicating poor sleep quality.  A score greater than 5 
indicates a clinically significant sleep disturbance. 
 In addition to capturing data regarding sleep patterns, we included validated measures for 
parental fear of hypoglycemia (Hypoglycemia Fear Survey [HFS-P]; range 0-104 with higher 
score indicating more fear) and parental emotional wellbeing (World Health Organization-Five-
Wellbeing Index [WHO-5]; range 0-100 with high score indicating better well-being).  
Nighttime caregiving habits also were captured from parents and reported as frequency per week 
of a caregiver checking the child’s blood sugar after bedtime.  Information regarding diabetes 
history and demographic variables (gender, race/ethnicity, parent education, annual household 
income, and insurance status) were also obtained from the parent.  Parents were asked to report 
on most recent HbA1c value, episodes of severe hypoglycemia (SH), and episodes of DKA over 
the previous 3 months. 
2.3 T1D Exchange Clinic Registry Data 
In addition to self-reported survey data, supplementary demographic and clinical data 
were obtained from T1D Exchange clinic registry medical chart extraction for survey 
respondents and non-respondents.  Demographic T1D Exchange variables used to compare 
respondents and non-respondents included the following: age, sex, race/ethnicity, health 
insurance type, use of insulin pump, CGM use, most recent HbA1c, and age at type 1 diagnosis. 
Self-reported HbA1c values were used for the main respondent analysis because a 
significant number of respondents did not have clinic-reported HbA1c values within 6 months of 
survey administration.  However, a sub-analysis of participants who had recent T1D Exchange 
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clinical HbA1c data (93 (18%) participants) revealed that self-reported HbA1c was only slightly 
lower than clinic-reported values (median difference 0.1% (inter-quartile range -0.2% to 0.5%)).  
Further, the difference in self-reported and clinic-reported HbA1c was not associated with CSHQ 
score or PSQI score (P=0.76, 0.19, 0.98, respectively, from separate linear regression models). 
2.4 Survey Administration 
The T1D Exchange Clinic Network has enrolled over 30,000 individuals with type 1 
diabetes across 74 U.S.-based pediatric and adult endocrinology practices.  Details on the 
eligibility criteria, informed consent process, and data collection for the T1D Exchange Clinic 
Network have been previously published (20).  Parents of T1D Exchange clinic registry 
participants 2-12 years of age with type 1 diabetes duration of at least one year who consented to 
receive emailed information regarding T1D Exchange studies were invited to participate via 2 
email waves between June 2015 and September 2015.  After signing an institutional review 
board-approved electronic informed consent form, parents of eligible participants completed the 
online surveys.  Study data were collected and managed using Research Electronic Data Capture 
(REDCap) tools hosted at the Jaeb Center for Health Research (21).  REDCap is a secure web-
based application designed to support data capture for research studies, providing; 1) an intuitive 
interface for validated data entry, 2) audit trails for tracking data manipulation and export 
procedures, 3) automated export procedures for seamless data downloads to common statistical 
packages, and 4) procedures for importing data from external sources.  Survey respondents 
received their choice of a $20 electronic gift card or donation to a diabetes charity. 
2.5 Statistical Analysis 
 The study was designed to include a feasibility sample (not based on statistical 
principles) of 500 participants.  Summary statistics were calculated for duration of sleep 
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according to age group (2-4 years old, 5-12 years old, parents) and for CSHQ score.  The 
proportion of CSHQ scores meeting the definition of poor sleep quality (score >41) was 
calculated.  The association between each of the following parent-reported outcomes and CSHQ 
score were examined: most recent HbA1c, frequency of BGM, use of insulin pump, CGM use, 
WHO-5 score, PSQI score, occurrence of ≥1 SH events in the 3 months prior to questionnaire 
completion, and occurrence of ≥1 DKA events in the 3 months prior to questionnaire completion.  
For continuous outcomes (HbA1c, frequency of BGM, WHO-5 score and PSQI score), separate 
multivariable linear regression models were used to assess the association with continuous 
CSHQ score; for categorical outcomes (insulin modality, CGM use, occurrence of ≥1 SH events, 
and occurrence of ≥1 DKA events), separate multivariable logistic regression models were used 
to assess the association with CSHQ score.  The associations between CSHQ (outcome) and 
parental fear of hypoglycemia and nocturnal caregiver behavior were assessed through separate 
multivariable linear regression models.  The association between parental nocturnal caregiver 
behavior and parental fear of hypoglycemia was examined through an ordinal logistic regression 
model.  Methods assessing association between outcomes and CSHQ score were repeated to 
assess the association between outcomes and parental report of child sleep duration.  
 Summary statistics of the PSQI score were calculated, and the proportion of PSQI scores 
meeting the definition of poor sleep quality (score >5) was determined.  The association between 
PSQI score and parental fear of hypoglycemia and nocturnal caregiver behavior was assessed 
through separate multivariable linear regression models.  
Results are expressed as mean±Standard Deviation for normally distributed variables or 
median (interquartile range) for non-normally distributed variables.  To account for possible 
confounding, the following covariates were assessed for association with each outcome through 
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univariate analysis and selection models: race/ethnicity, age, sex, age at T1D diagnosis, 
insurance status, clinic center, and insulin modality (assessed if insulin modality was not the 
outcome of interest).  If an association with an outcome was present, the covariate was included 
in the model for the outcome. 
Data analyses were performed using SAS software version 9.4 (SAS Institute Inc., Cary, 
NC).  In view of the multiple comparisons, only p-values <0.01 were considered significant. 
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3.1 Results 
 Between June 2015 and September 2015, 2,356 parents of eligible participants from 54 
pediatric diabetes centers were sent a survey invitation via email; 598 (25%) accessed the 
survey and 515 (22%) from 50 of the 54 clinics completed the survey (all who completed the 
survey were analyzed). 
 The 515 surveys were completed by parents of children who had a mean age of 9±3 
years, 240 (47%) children were female, and 442 (86%) non-Hispanic White.  Mean age of the 
child at diagnosis was 4±2 years.  Mean parent-reported HbA1c was 7.8%±0.9% (62±9.8 
mmol/mol); median number of blood glucose checks per day was 7.0 (6.0, 9.0).  Occurrence 
of at least one SH event in the 3 months prior to questionnaire completion was reported by 
parents of 15 children (3%), and occurrence of at least one DKA event was reported by 
parents of 30 children (6%).  Additional characteristics of the cohort are shown in Table 1. 
 Compared with participants who did not complete the survey, participants who 
completed the survey were more likely to be non-Hispanic White (86% vs. 78%), use an 
insulin pump (77% vs. 68%), use a CGM (27% vs. 19%), and have lower clinic-reported 
HbA1c (mean 8.0% vs 8.4% [64 vs 68 mmol/mol]) (Supplemental Table 1). 
 
3.2 Summary of Scores 
 Mean duration of sleep per night was 10.9±1.2 hours in children 2-4 years old, 9.5±1.0 
hours in children 5-12 years old (22), and 6.5±1.2 hours in parents (Supplemental Figure 1).  
Among the 511 children with sleep duration reported, 103 (20%) reported sleep duration 
below the recommended amount (<9 hours/night); among 504 parents with sleep duration 
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reported, 259 (51%) reported sleep duration below the recommended amount (<7 
hours/night). 
   Three hundred forty-six (67%) children met criteria for poor sleep quality (CSHQ 
score >41).  Among the 501 parents with PSQI score measured, 266 (53%) met criteria for 
poor sleep quality (score >5).  About one-third of parents (163 [32%]) met the WHO-5 criteria 
for low mood (score ≥50) (23). Most participants (355 [69%]) often or always had a caregiver 
check the child’s blood glucose value after the child’s bedtime; only 17 (3%) never checked 
the child’s blood glucose value after bedtime. 
3.3 Associations with CSHQ 
 Children with poor sleep quality (high CSHQ score) had higher HbA1c than children 
with non-poor sleep quality (P<0.001 for continuous score adjusted for race/ethnicity, 
insurance status, and clinic center) (Figure 1A).  Frequency of BGM per day was not 
associated with child sleep quality (P=0.56 adjusted for race/ethnicity, insurance status, 
diagnosis age, insulin modality, and clinic center).  Children with poor sleep quality were 
more likely to experience at least one SH event in the 3 months prior to questionnaire 
completion (P=0.05 adjusted for race/ethnicity, gender, type of insurance, and HFS score; 
Figure 1B) and were more likely to experience at least one DKA event in the 3 months prior 
to questionnaire completion (P<0.001 adjusted for race/ethnicity, type of insurance, and use of 
an insulin pump; Figure 1C).  Poor child sleep quality was associated with worse parental 
wellbeing (P<0.001 adjusted for race/ethnicity and child age; Figure 1D) and worse parental 
sleep quality (P<0.001 adjusted for race/ethnicity and sex; Figure 1E).  Insulin modality was 
not associated with child sleep quality (P=0.13 adjusted for race/ethnicity, sex, insurance 
status, and diagnosis age); use of CGM also was not associated with child sleep quality 
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(P=0.96 adjusted for race/ethnicity, child age, sex, insurance status, age at diagnosis, and 
insulin modality). 
 Children of parents with more fear of hypoglycemia (high HFS score) had worse sleep 
quality than children of parents with less fear of hypoglycemia (P<0.001 adjusted for 
race/ethnicity, child age, insurance status, clinic center; Figure 2A).  Parents with more fear of 
hypoglycemia were more likely to more frequently check their child’s blood glucose level 
after the child’s bedtime (P=0.005 adjusted for race/ethnicity, child age, age at diagnosis, and 
insulin modality).  However, child sleep quality was not associated with frequency of 
nocturnal checking of blood glucose (P=0.66; Figure 2A).   
3.4 Associations with Parental Report of Child Sleep Duration 
 Associations with sleep duration were similar to associations with child sleep quality.  
Participants with shorter sleep duration had: higher HbA1c (8.0% in participants with <9 
hours/night vs 7.8% in participants with >9 hours/night; adjusted P=0.02), worse parental 
wellbeing (WHO score 54 for participants with <9 hours/night vs 58 with >9 hours/night; 
adjusted P=0.01), and worse parental sleep quality (PSQI score 7 in participants with <9 
hours/night vs 6 in participants with >9 hours/night; adjusted P=0.01).  Sleep duration was not 
associated with frequency of blood glucose checks (adjusted P=0.66) or CGM use (P=0.31), 
however, there was a trend for participants with longer duration of sleep to be more likely to 
use an insulin pump (68% in participants with <9 hours/night vs 82% in participants with >9 
hours/night; adjusted P=0.06).  
3.4 Associations with PSQI 
 Similar to child sleep quality, parents with more fear of hypoglycemia had worse sleep 
quality than parents with less fear of hypoglycemia (P<0.001 adjusted for race/ethnicity and 
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sex; Figure 2B).  However, frequency of nocturnal checking of blood glucose was not 
associated with parental sleep quality (P=0.35; Figure 2B). 
4.1 Discussion 
The current study is the largest descriptive study of sleep in children with type 1 
diabetes and their parents and yielded several important findings. A significant percentage of 
children and parents met clinical criteria for sleep disturbances. Further, 20% of children and 
50% of parents did not meet the recommended duration for sleep.  Child sleep disturbances 
were significantly associated with glycemic control, such that those who met the clinical 
criteria for sleep disturbances had significantly poorer glycemic control than those who did 
not have clinically significant sleep disturbances (parent-reported HbA1c=7.9% vs 7.6% [63 
vs 60 mmol/mol]), and children with poor sleep quality were more likely to have experienced 
at least one event of SH and DKA.  In addition, child sleep disturbances were significantly 
related to parents’ own reported sleep quality and parental well-being. 
In line with our hypothesis, child sleep quality and duration were significantly related 
to HbA1c. While the relationship between sleep and glycemic control is likely bidirectional, 
experimental studies offer support for the effect of sleep restriction or disturbances to sleep 
quality (suppressing slow wave sleep) on insulin resistance and elevated blood glucose (9, 11, 
12).  However, contrary to our hypothesis, we did not find a significant association between 
child sleep and a measure of adherence (frequency of BGM).  Given that parents are primarily 
responsible for diabetes management in younger children, it may be that associations between 
sleep disturbances and adherence will be evident in older individuals, who engaged in more 
self-management (adolescents and adults).  Further, as we only assessed one adherence 
behavior, it remains to be determined whether other adherence behaviors (e.g., mealtime 
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insulin bolus, corrections for hyperglycemia) are associated with sleep quality or sleep 
duration in children. 
Child sleep also was associated with parent sleep and parental well-being, in line with 
findings from smaller studies of sleep in young children with type 1 diabetes (4, 24).  Child 
sleep disturbances are a source of stress for parents, and parents’ own lack of sleep and poor 
sleep quality are likely to have a negative impact on their emotional wellbeing (25).  Even 
though parents’ fear of hypoglycemia was associated with greater nocturnal caregiving and 
poorer sleep quality in children, there was no association between nocturnal caregiving and 
child sleep.  Further, the lack of association between CGM use and parental or child sleep 
quality was surprising, given that many parents express interest in using CGM as a way to 
reduce anxiety around nocturnal hypoglycemia and reduce the need for nocturnal caregiving. 
It may be that objective measures of sleep are needed to demonstrate the impact of CGM on 
sleep, rather than self-report (26).  Alternatively, it is possible that parents with the greatest 
fear of hypoglycemia were early adopters of CGM, but given the cross-sectional design of the 
study, we cannot know if fear of hypoglycemia changed with CGM use.  Finally, the potential 
for alterations in insulin delivery based on CGM data (i.e., closed loop systems) may have 
greater potential to improve parents’ sleep quality than data alone. 
The current study is limited by the use of parent-report measures of child sleep and 
HbA1c and the cross-sectional design.  Future studies should use more objective measures of 
sleep (actigraphy, polysomnography), longitudinal designs, and consider including a matched 
sample of children without diabetes.  It is also important to note that the HFS-P was validated 
for use in children ages 8-15, and our sample included children ages 2-12.  In addition, given 
the demographic and clinical differences in parents who completed the survey as compared to 
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the total clinic registry sample, findings may not generalize to other samples with lower use of 
diabetes-related technology or poorer glycemic control.  However, this study was the first to 
examine sleep in a large, nationally distributed sample of young children with type 1 diabetes. 
5.1 Conclusions 
 
Sleep is an understudied and potentially important influence on glycemic control, and 
sleep quality may be a viable target for interventions to improve outcomes in youth with type 
1 diabetes. In children without diabetes, behavioral interventions have resulted in significant 
improvements in sleep disturbance (2); a recent study demonstrated that an increase of even 15-
20 minutes of sleep was associated with an additional BGM check and additional insulin bolus 
(15).  Further, sleep disturbances observed in young children are likely to persist into 
adolescence, so it may be important to intervene at an early age (27).  Given that most children 
with type 1 diabetes are not meeting treatment goals (28), and that parents of children experience 
high levels of distress related to diabetes management (29), the current study offers support for 
targeting sleep as a potentially modifiable risk factor for these outcomes in children with type 1 
diabetes.  
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Table 1. Parent-Reported Characteristics  
 
  
Overall 
N=515 
Child Characteristics 
Age (years) - mean ± SD 9 ± 3 
Age at diagnosis (years) – median 
(25th %ile, 75th %ile) 
 
3 (2,5) 
Femalea – n(%) 240 (47%) 
Race/ethnicity – n(%)  
White Non-Hispanic 442 (86%) 
Black Non-Hispanic 20 (4%) 
Hispanic or Latino 16 (3%) 
Other Race/Ethnicity 37 (7%) 
Insurance statusa – n(%)  
Private insurance 408 (81%) 
Other insurance 90 (18%) 
No insurance 3 (<1%) 
Insulin modalitya – n(%)  
Insulin pump 403 (80%) 
Multiple daily insulin injections 103 (20%) 
Uses a Continuous Glucose 
Monitor – n(%) 
 
199 (39%) 
Parent-reported Most Recent 
HbA1c – mean ± SD 
 
7.8% ± 0.9% 
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Frequency of monitoring of blood 
glucose – mean ± SD 
 
7.4 ± 2.4 
Occurrence of >1 severe 
hypoglycemia eventsab 
 
15 (3%) 
Occurrence of >1 DKA eventsb  
30 (6%) 
Parent Characteristics 
Education levelab – n(%)  
High school diploma or less 134 (26%) 
Vocational or college degree 255 (50%) 
Graduate or professional degree 124 (24%) 
a1 transgender participant; education level missing for 2 participants; insurance status missing for 14 
participants; insulin modality missing for 9 participants; frequency of self-monitoring of blood glucose 
missing for 1 participant; occurrence of severe hypoglycemia event information missing for 2 participants 
bAt least one event experienced in the 3 months prior to questionnaire completion 
cHighest parental education level 
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Table 2. Summary of Scores 
 Overall 
N=515 
CSHQ (child sleep disturbance) – mean ± SD 45.8 ± 7.7 
Score >41 (poor sleep quality) – n(%) 346 (67%) 
PSQI (parental sleep quality)a – mean ± SD 6.6 ± 3.4 
Score >5 (poor sleep quality) – n(%) 266 (53%) 
Hypoglycemia Fear – mean ± SD 43.2 ± 12.8 
WHO-5 – mean ± SD 57.4 ± 17.5 
Score >50 (low mood) – n(%) 163 (32%) 
Frequency of nocturnal checks – n(%)  
Never 17 (3%) 
Sometimes 143 (28%) 
Often/always 355 (69%) 
aPSQI score missing for 14 participants  
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Figure 1A. Association between Parent-Reported HbA1c and Child Sleep Disturbances 
(CSHQ) 
 
aP-value calculated from linear regression model adjusting for clinic site, race/ethnicity, and 
insurance status 
Figure 1B. Association between Occurrence of >1 Severe Hypoglycemia Events in the 3 
Months Prior to Questionnaire Completion and Child Sleep Disturbances (CSHQ) 
 
aP-value from a multivariable logistic regression model adjusting for race/ethnicity, sex, type of 
insurance, and fear of hypoglycemia score (HFS survey score) 
T1DX_SleepInChildrenManuscript 05_05_17-Clean                                     Page 24 of 30 
 
Figure 1C. Association between Occurrence of >1 DKA Events in the 3 Months Prior to 
Questionnaire Completion and Child Sleep Disturbances (CSHQ) 
 
aP-value from a multivariable logistic regression model adjusting for race/ethnicity, type of 
insurance, and use of an insulin pump 
Figure 1D. Association between Parental Well-Being (WHO-5) and Child Sleep 
Disturbances (CSHQ) 
 
a P-value calculated from linear regression model adjusting for race/ethnicity and child age at 
start of questionnaire 
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Figure 1E. Association between Parental Sleep Quality (PSQI) and Child Sleep 
Disturbances (CSHQ) 
 
a P-value calculated from linear regression model adjusting for race/ethnicity and sex 
 
Figure 2A. Characteristics Associated with Child Sleep Disturbances (CSHQ) 
 
a P-value calculated from a linear regression model adjusted for clinic site, race/ethnicity, and 
child age at questionnaire start 
T1DX_SleepInChildrenManuscript 05_05_17-Clean                                     Page 26 of 30 
 
Figure 2B. Characteristics Associated with Parental Sleep Quality (PSQI) 
 
a P-value calculated from a linear regression model adjusted for race/ethnicity and sex 
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Supplemental Table 1. T1D Exchange Clinic Registry Characteristics of Study Completers 
vs. Study Non-Completersa 
 
  
Completed Survey 
N=515 
Sent Survey but Did not 
Complete Survey 
N=1841 
Age (years) – mean ± SD 9 ± 3 10 ± 2 
Femaleb – n(%) 241 (47%) 848 (46%) 
Race/ethnicityb – n(%)   
White Non-Hispanic 439 (85%) 1438 (78%) 
Black Non-Hispanic 16 (3%) 111 (6%) 
Hispanic or Latino 27 (5%) 168 (9%) 
Other Race/Ethnicity 26 (5%) 107 (6%) 
Type of health insuranceb – (n%)   
Private insurance 383 (76%) 1305 (74%) 
Other insurance 121 (24%) 444 (25%) 
No insurance 2 (<1%) 4 (<1%) 
Insulin modalityb – n(%)   
Insulin pump 394 (77%) 1250 (68%) 
Multiple daily insulin injections 120 (23%) 590 (32%) 
Uses a Continuous Glucose Monitor 
– n(%) 
 
139 (27%) 
 
343 (19%) 
HbA1c – mean ± SD 8.0% ± 1.1% 8.4% ± 1.3% 
Age at diagnosis (years) – median 
(25th %ile, 75th %ile) 
 
3 (2,6) 
 
4 (2, 6) 
aData collected and stored as part of the participant’s involvement in the T1D Exchange clinic registry.   
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bRace/ethnicity information missing for 24 participants; insurance information missing for 97 
participants; insulin modality information missing for 2 participant 
 
 
Supplemental Figure 1. Average Reported Sleep Duration vs Recommended Sleep 
Duration 
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